Dr. Todd Michael Hrabak, DO

Dr. Hrabak practices at Arizona Plastic Surgery Institute in Glendale, Arizona.

Dr. Hrabak's NPI, 1801821152, was assigned on July 12, 2006. Dr. Hrabak graduated from Philadelphia College of Osteopathic Medicine in 2000. Dr. Hrabak holds Arizona license 4812.

Dr. Hrabak's primary practice is Arizona Plastic Surgery Institute, at 5750 W Thunderbird Rd, Glendale, AZ 85306 in Maricopa County. The practice phone is (602) 547-2774.

Dr. Hrabak's primary practice is Arizona Plastic Surgery Institute in Glendale, Arizona. Dr. Hrabak is also affiliated with Banner Thunderbird Medical Center. The medical group on file is Sunrise Medical Center. Dmand AI also links Dr. Hrabak to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hrabak practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Hrabak's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Hrabak is board certified in 2002 - 2008 by the AL State License. Dr. Hrabak is licensed in Arizona.

Dmand AI lists asthma, chronic nasal allergies, chronic sinusitis, hives and immune deficiency disease among the conditions Dr. Hrabak treats.

CMS data shows 14,698 Medicare services from Dr. Hrabak across 19 procedure codes in 2024, for 304 Medicare patients. Medicare paid $200,440 for them. Every service was in an office.

CMS counts 304 Medicare patients who saw Dr. Hrabak in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hrabak's median patient age at 65, with 64% women.

In 2024, Dr. Hrabak wrote 1,531 Medicare Part D claims for 314 patients. 49% of them were for generic drugs. CMS names the drug for 1,374 of them, across 27 drugs with 11 or more claims each, at $2,204,375 in total drug cost. In 2023, CMS named 1,315 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Hrabak for performance year 2024, reported as part of a group. Dr. Hrabak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Hrabak. The most frequent topics are Allergens. Dr. Hrabak has published most often in Ann Allergy Asthma Immunol. Dr. Hrabak's most frequent co-authors are April Michelle Arseneau, MD, Christopher Calabria, MD and John Patrick Dice, MD.

CMS Open Payments shows 1,716 general payments to Dr. Hrabak from 49 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. CSL Behring paid the most, $182,466.

Dr. Hrabak graduated from Philadelphia College of Osteopathic Medicine in 2000. Dr. Hrabak is a member of AAAAI.

Dr. Hrabak is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.